Skip to main content

UBS Group AG

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in RNAC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,174,101
+$1,332,536 QoQ
Shares Held
208,647
+52.5% QoQ
Ownership
0.690%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 95 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. RNAC ranks #210 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RNAC

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,174,101 208,647
2026-03-31 $841,565 136,840
2025-12-31 $485,527 67,341
2025-09-30 $101,668 9,948
2025-06-30 $137,209 13,206
2025-03-31 $410,134 31,118
2024-12-31 $314,857 17,580
2024-09-30 $86,064 5,339
2024-06-30 $60,420 2,237
2024-03-31 $76,325 117,426
2023-12-31 $90,784 131,764
2023-09-30 $63,917 60,300
2023-06-30 $71,246 63,613
2022-09-30 $18,207 11,102
2022-03-31 $1,440 1,171
2021-12-31 $82,451 25,292
2021-09-30 $622,480 149,635
2021-06-30 $23,929 5,725
2021-03-31 $1,347,540 297,799
2020-12-31 $302 100
2020-09-30 $948 383
2020-06-30 $90,513 31,871